ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS

News

High-Tech Gründerfonds invests in the medical technology of the future

17. Octo­ber 2018

Frank­furt a. M. — Kumo­vis deve­lops 3D prin­ters speci­fi­cally for medi­cal tech­no­logy and enab­les with its tech­no­logy, for example, the produc­tion of pati­ent-adap­­ted implants. HTGF is now parti­ci­pa­ting in a seven-figure seed finan­cing toge­ther with a family office and is thus suppor­ting the company in the market launch of the inno­va­tive printers.

The foun­ders of Kumo­vis GmbH, inclu­ding mana­ging direc­tor Dr.-Ing. Miriam Haerst (photo), have set them­sel­ves the goal of enab­ling the addi­tive produc­tion of plastic implants and are deve­lo­ping inno­va­tive 3D prin­ters for this purpose. The prin­ters are specially tailo­red to medi­cal tech­no­logy requi­re­ments. The focus is on the proces­sing of high-perfor­­mance poly­mers, such as PEEK or PPSU, which are already estab­lis­hed in medi­cal tech­no­logy and appro­ved for the manu­fac­ture of medi­cal devices. — The Munich-based high-tech startup has recei­ved a lot of encou­ra­ge­ment from indus­try and the startup scene in recent months, and has won the Munich Busi­ness Plan Compe­ti­tion, for example.

Dr. Cars­ten Rudolph, Mana­ging Direc­tor BayStartUP: “Kumo­vis offers a very good combi­na­tion of digi­ta­liz­a­tion and medi­cal tech­no­logy. In the three phases in the Munich Busi­ness Plan Compe­ti­tion this year, we could observe a strong deve­lo­p­ment of the foun­ders, and the team has syste­ma­ti­cally advan­ced its company.”

Thanks to the comple­ted seed finan­cing round in the seven-figure range with HTGF and a family office, the young company can now prepare its market entry.

About Kumo­vis GmbH
In Octo­ber 2017, Kumo­vis GmbH was foun­ded as a spin-off of the TU Munich. The foun­ders deve­lo­ped the first idea for this in 2016 as part of their acti­vi­ties at the Chair of Medi­cal Tech­no­logy and were able to build and test the first proto­ty­pes with the support of the EXIST Forschungs­trans­fer funding program and funding from ESA BIC Bavaria.

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de